BASECAMP
Live / Registered — Registered (as of 14 Mar 2023)
What this means for you
Registered since 14 Mar 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97241251
- Registration number
- 7002127
- Mark type
- Stylized text
- Filed
- 27 Jan 2022
- Published for opposition
- 26 Jul 2022
- Registered
- 14 Mar 2023
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research services; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of vaccines and medicines; Research and development services in the field of antibodies; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Biochemical research and development; Conducting early evaluations in the field of new pharmaceuticals; Consulting services in the fields of biotechnology, pharmaceutical research and development, and pharmacogenetics; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Medical and scientific research in the field of cancer treatment and diagnosis; Medical research services in the field of cancer; Pharmaceutical research and development; Product research and development; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing medical testing services and information in the field of cancer research and disease classification; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Scientific research and development; Scientific research for medical purposes in the area of cancerous diseases; Technical consulting in the field of pharmaceutical studies; Technical research in the field of pharmaceutical studies; Testing of pharmaceuticals; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
Owner
- ElevateBio, LLC, Cambridge, MA, US
- ElevateBio, LLC, Cambridge, MA, US
- ElevateBio, LLC, Cambridge, MA, US
Prosecution history
- 14 Mar 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 14 Mar 2023 — REGISTERED-PRINCIPAL REGISTER
- 07 Feb 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 06 Feb 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 09 Jan 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 04 Jan 2023 — USE AMENDMENT FILED
- 04 Jan 2023 — TEAS STATEMENT OF USE RECEIVED
- 13 Oct 2022 — CORRECTED NOA E-MAILED
- 12 Oct 2022 — NOTICE OF ALLOWANCE CORRECTION ENTERED
- 12 Oct 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 23 Sept 2022 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 20 Sept 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 26 Jul 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Jul 2022 — PUBLISHED FOR OPPOSITION
- 06 Jul 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED